WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 6.4111

Change

+0.04 (+0.64)%

Market Cap

N/A

Volume

69.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.44 (-1.01%)

USD 64.67B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.40 (-0.08%)

USD 10.34B
WRD:PA HSBC ETFs Public Limited Compa..

-0.07 (-0.22%)

USD 9.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.69 (-0.28%)

USD 7.53B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.40 (+0.10%)

USD 6.82B
HHH:PA HSBC ETFs Public Limited Compa..

-0.04 (-0.07%)

USD 6.65B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.80 (-0.25%)

USD 6.26B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.03 (-0.20%)

USD 4.96B
500U:PA Amundi Index Solutions - Amund..

-0.18 (-0.17%)

USD 4.71B
WSRI:PA Amundi MSCI World SRI Climate ..

-0.33 (-0.35%)

USD 4.01B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.14% 12% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.14% 58% F 31% F
Trailing 12 Months  
Capital Gain -7.57% 9% A- 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.57% 9% A- 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.44% 18% F 30% F
Dividend Return -1.44% 60% D- 28% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.97% 94% A 96% N/A
Risk Adjusted Return -48.58% 56% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike